Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2024 Earnings Call Transcript August 9, 2024
Acurx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-260.46863 EPS, expectations were $-0.28.
Operator: Greetings. Welcome to the Acurx Pharmaceuticals Second Quarter 2024 Financial Results. At this time, all participants are in listen-only mode. Question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being...
